Replies to post #609367 on NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

I agree he and many of us have significant capital deployed in this stock. It makes sense that we urge management to speak about these matters but in reality they may not be able to at this time due to DCVax being before regulators.

It could be better to time such information with regulatory updates as we need momentum for an uplist. This situation seems very similar the months between May and November 2022. In the end it worked out great. Let's let management deliver.

[skitahoe]

Flipper, while I'd agree if submissions have been made to all regulators. If on the other hand it's only been made to one regulator, I think the work should be in making the other submissions.

If everything is held up based on the FlaskWorks EDEN approval, but otherwise all paperwork is complete, I agree that they should be getting into advancing other things while the FlaskWorks team is completing their work. I believe they may need some serious additional funds before new trials can begin and hope that they can do so at substantially higher share prices that result from approvals, so I really don't know that new trials will start before then. The planning effort for such trials should certainly be underway now.

Gary